{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:13:20Z","timestamp":1789010000775,"version":"build-2803163510"},"reference-count":27,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hematopoietically restricted minor histocompatibility antigens (miHAs) presented on HLA-class I molecules are ideal targets for adoptive T-cell immunotherapy in the context of an allogeneic stem cell transplant (alloSCT). This is because CD8 cells that recognize these miHAs can mediate potent antileukemia effects with a low risk for graft-versus-host disease (GVHD). A barrier to translating this concept broadly to the clinic has been the difficulty and expense of cloning potentially high-value T-cell receptors (TCRs). Here, we describe the isolation of anti-miHA TCRs using a novel high-throughput platform (TCXpress) that enables the rapid cloning and characterization of TCRs from single cells without nucleic acid sequencing or gene synthesis. We cloned 7 unique TCRs recognizing the miHA HA-1H from 50 mL of blood from an HLA-A\u221702:01 HA-1R\/R woman who was immunized against HA-1H during pregnancy. After in vitro expansion, 13 additional unique anti-HA-1H TCRs were cloned from 740 HA-1H-dextramer+ cells, with the screen completed in 35 days. We also cloned 12 unique anti-HA-2V TCRs from 771 HA-2V-tetramer+ cells from a patient with myelodysplastic syndrome (MDS) that had relapsed after alloSCT and who received a donor leukocyte infusion. Ten anti-HA-2V TCRs were isolated from an unmanipulated sample collected at GVHD-onset, and 8 were isolated when GVHD and MDS were in remission. Anti-HA-1H and -HA-2V TCRs had a wide range of avidities measured by activation of cell lines expressing them. Taken together, our results validate a new method for TCR isolation and characterization with potentially broad applications, and provide insights into the nature of anti-miHA responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017680","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:22:31Z","timestamp":1761913351000},"page":"1114-1125","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-0234","authenticated-orcid":false,"given":"Sawa","family":"Ito","sequence":"first","affiliation":[{"name":"1Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA"},{"name":"2Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA"},{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Martin","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Panousis","sequence":"additional","affiliation":[{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"},{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7265-6437","authenticated-orcid":false,"given":"Alexander M.","family":"Rowe","sequence":"additional","affiliation":[{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Stras","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Roy","sequence":"additional","affiliation":[{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"},{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio Brocca","family":"Cofano","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedwin","family":"Ventura","sequence":"additional","affiliation":[{"name":"1Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7625-9268","authenticated-orcid":false,"given":"Kayla","family":"Parr","sequence":"additional","affiliation":[{"name":"1Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswas","family":"Neupane","sequence":"additional","affiliation":[{"name":"1Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bellesis","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn","family":"Toki","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jing","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeung","family":"Jang","sequence":"additional","affiliation":[{"name":"4BlueSphere Bio, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Turqueti","family":"Neves","sequence":"additional","affiliation":[{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Shlomchik","sequence":"additional","affiliation":[{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren D.","family":"Shlomchik","sequence":"additional","affiliation":[{"name":"1Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA"},{"name":"2Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA"},{"name":"3Department of Immunology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"5","key":"2026022411371234800_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199602013340501","article-title":"Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation","volume":"334","author":"Goulmy","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"2026022411371234800_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bmt.2015.256","article-title":"Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives","volume":"51","author":"Oostvogels","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2026022411371234800_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/icb.2010.124","article-title":"Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia","volume":"89","author":"Bleakley","year":"2011","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"2026022411371234800_bib4","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2007-11-125294","article-title":"CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL","volume":"111","author":"Matte-Martone","year":"2008","journal-title":"Blood"},{"issue":"22","key":"2026022411371234800_bib5","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1182\/blood-2011-07-367011","article-title":"Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2026022411371234800_bib6","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-020-17991-y","article-title":"T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"issue":"5353","key":"2026022411371234800_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.279.5353.1054","article-title":"The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism","volume":"279","author":"den Haan","year":"1998","journal-title":"Science"},{"issue":"5","key":"2026022411371234800_bib8","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026022411371234800_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2026022411371234800_bib10","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3389\/fimmu.2020.01804","article-title":"HA-1H T-cell receptor gene transfer to redirect virus-specific T cells for treatment of hematological malignancies after allogeneic stem cell transplantation: a phase 1 clinical study","volume":"11","author":"van Balen","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"2026022411371234800_bib11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.2024024105","article-title":"HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation","volume":"144","author":"Krakow","year":"2024","journal-title":"Blood"},{"issue":"suppl 1","key":"2026022411371234800_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2024-201526","article-title":"TSC-100 and TSC-101 demonstrate the potential to reduce relapse rates and increase relapse-free survival in patients with AML, ALL, or MDS undergoing allogeneic HCT with reduced intensity conditioning (RIC): preliminary results from the phase 1 Alloha trial","volume":"144","author":"Al Malki","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2026022411371234800_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood-2017-07-791608","article-title":"Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse","volume":"131","author":"Dossa","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2026022411371234800_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood.V83.4.1060.1060","article-title":"Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones","volume":"83","author":"van der Harst","year":"1994","journal-title":"Blood"},{"issue":"5","key":"2026022411371234800_bib15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2003-05-1625","article-title":"Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy","volume":"103","author":"Verdijk","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2026022411371234800_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","article-title":"Enzymatic assembly of DNA molecules up to several hundred kilobases","volume":"6","author":"Gibson","year":"2009","journal-title":"Nat Methods"},{"issue":"1","key":"2026022411371234800_bib17","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/s41467-019-12441-w","article-title":"Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function","volume":"10","author":"Thomas","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"2026022411371234800_bib18","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1073\/pnas.0900411106","article-title":"Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition","volume":"106","author":"Nicholls","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2026022411371234800_bib19","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1101\/gr.092924.109","article-title":"Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing","volume":"19","author":"Freeman","year":"2009","journal-title":"Genome Res"},{"issue":"9","key":"2026022411371234800_bib20","doi-asserted-by":"crossref","first-page":"e190655","DOI":"10.1172\/jci.insight.190655","article-title":"IFN-gamma and donor leukocyte infusions for relapsed myeloblastic malignancies after allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Ito","year":"2025","journal-title":"JCI Insight"},{"issue":"10","key":"2026022411371234800_bib21","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2003-05-1524","article-title":"Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region","volume":"102","author":"Heemskerk","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2026022411371234800_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bmt.1705689","article-title":"The HLA-A\u22170201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A\u22170206","volume":"40","author":"Torikai","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2026022411371234800_bib23","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1002\/cpim.97","article-title":"T cell receptor engineered lymphocytes for cancer therapy","volume":"129","author":"Rollins","year":"2020","journal-title":"Curr Protoc Immunol"},{"issue":"2","key":"2026022411371234800_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/eji.202149392","article-title":"An efficient single-cell based method for linking human T cell phenotype to T cell receptor sequence and specificity","volume":"52","author":"Wahl","year":"2022","journal-title":"Eur J Immunol"},{"issue":"8","key":"2026022411371234800_bib25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/eji.201848030","article-title":"High-throughput single-cell sequencing of paired TCRalpha and TCRbeta genes for the direct expression-cloning and functional analysis of murine T-cell receptors","volume":"49","author":"Ludwig","year":"2019","journal-title":"Eur J Immunol"},{"issue":"4","key":"2026022411371234800_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41590-020-0628-2","article-title":"Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection","volume":"21","author":"Schober","year":"2020","journal-title":"Nat Immunol"},{"issue":"4","key":"2026022411371234800_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41590-020-0639-z","article-title":"'Reverse evolution' in T cell biology","volume":"21","author":"Redeker","year":"2020","journal-title":"Nat Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1114\/2503277\/blooda_adv-2025-017680-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1114\/2503277\/blooda_adv-2025-017680-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:37:19Z","timestamp":1771951039000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/4\/1114\/547999\/High-throughput-cloning-reveals-diverse-properties"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017680","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,24]]},"published":{"date-parts":[[2026,2,12]]}}}